Insulin Delivery Devices Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight

The global insulin delivery devices market was valued at USD 15.51 billion in 2023 and is projected to reach USD 26.35 billion by 2030, growing at a CAGR of 9.28% between 2024 and 2030. This growth is largely fueled by the rising incidence of diabetes, attributed to factors such as lifestyle changes, aging populations, and hereditary influences. Increased public awareness and education around diabetes care have also played a key role, helping patients and healthcare professionals understand the advantages of advanced insulin delivery systems-such as greater accuracy, ease of use, and better blood sugar control.

Moreover, technological progress has accelerated market expansion through innovations like smart insulin pumps, integration with continuous glucose monitors (CGMs), and mobile app connectivity. Together, these advancements are enhancing diabetes management and driving the increasing adoption of modern insulin delivery devices, thereby supporting improved health outcomes over the forecast period.

DelveInsight's Insulin Delivery Devices Market Insights report provides the current and forecast market analysis, individual leading Insulin Delivery Devices companies' market shares, challenges, Insulin Delivery Devices market drivers, barriers, and trends, and key Insulin Delivery Devices companies in the market.

Request for a sample report @ https://www.delveinsight.com/report-store/insulin-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Insulin Delivery Devices Market Report
• The Insulin Delivery Devices market is projected to grow at a moderate CAGR from 2025 to 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global Insulin Delivery Devices market during the forecast period.
• The Insulin Delivery Devices Market is expected to strengthen as disease awareness increases and more effective interventions are developed.
The leading Insulin Delivery Devices Companies such as Becton, Dickinson and Company, Medtronic, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo, CeQur, EOFLOW CO., LTD, European Pharma Group BV, Roche, Sanofi, Hindustan Syringes & Medical Devices Ltd, Ocean (Hangzhou) Medical Technology Co Ltd, Owen Mumford, SOOIL Developments Co., Ltd, SUNGSHIM MEDICAL CO., LTD, and others.

To read more about the latest highlights related to the Insulin Delivery Devices market, get a snapshot of the key highlights entailed in the Global Insulin Delivery Devices Market Report https://www.delveinsight.com/report-store/insulin-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Insulin Delivery Devices Overview
Insulin delivery devices are essential tools designed to administer insulin to individuals with diabetes, helping them manage blood glucose levels effectively. These devices offer alternatives to traditional syringes, improving convenience, accuracy, and patient adherence to insulin therapy.

Modern insulin delivery options include insulin pens, syringes, insulin pumps, and patch pumps, with increasing integration of smart technologies like mobile apps and continuous glucose monitoring (CGM) systems. These innovations are making insulin administration more personalized, discreet, and efficient.

The growing global burden of diabetes, especially among aging populations and younger individuals, is driving demand for advanced insulin delivery systems. Enhanced awareness, supportive healthcare policies, and continuous R&D efforts are further fueling market expansion and improving outcomes for diabetes management worldwide.

Insulin Delivery Devices Market Insights
North America is projected to dominate the insulin delivery devices market in 2023, primarily due to the rising prevalence of diabetes in the region. This growth is further supported by the strong presence of major industry players actively engaged in reimbursement strategies, mergers, acquisitions, and other market-expanding activities. Moreover, increased public awareness, along with a steady stream of product approvals and launches, is contributing to the region's expanding market share.

According to the latest data from the Centers for Disease Control and Prevention (CDC), an estimated 38.4 million people of all ages in the U.S.-approximately 11.6% of the population-were living with diabetes in 2021. Among adults aged 18 and older, 38.1 million individuals, or 14.7% of the adult population, were affected. These figures underscore the significant demand for advanced insulin delivery solutions across North America.


To know more about why North America is leading the market growth in the Insulin Delivery Devices market, get a snapshot of the Insulin Delivery Devices Market Outlook https://www.delveinsight.com/report-store/insulin-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Insulin Delivery Devices Market Dynamics
According to the International Diabetes Federation (IDF), around 537 million adults aged 20-79 were living with diabetes in 2021-a number expected to rise to 643 million by 2030 and 783 million by 2045. The same report noted that about 21.1 million live births globally (16.7%) were impacted by hyperglycemia during pregnancy, with women over 45 or those with a history of gestational diabetes at increased risk of developing type 2 diabetes later in life.

Furthermore, the IDF Diabetes Atlas 2022 highlighted that among the 8.75 million individuals globally living with Type 1 diabetes, 1.52 million were under 20 years of age. Notably, 62% of new Type 1 diabetes diagnoses that year occurred in people aged 20 or older. This age distribution emphasizes the need for adaptable insulin delivery devices suited for both pediatric and adult patients. Younger individuals especially benefit from user-friendly, discreet solutions like smart pens and patch pumps-driving market demand for innovative and lifestyle-compatible devices.

The industry is also seeing a significant trend toward wearable insulin delivery technologies. Devices such as insulin pumps and patch pumps provide continuous, discreet insulin infusion, aligning with patient preferences for convenience and mobility. A notable development includes PharmaSens, a Swiss medical device company, which submitted its FDA application in January 2024 for the 'niia essential' insulin patch pump system in the U.S. market. This follows the company's achievement of ISO 13485 certification in November 2023 for its insulin pump design, development, manufacturing, and distribution processes-demonstrating a strong commitment to patient-centered innovation.


Insulin Delivery Devices Market Drivers:
The growing demand for insulin delivery devices is primarily fueled by the rising incidence of diabetes, which is linked to lifestyle shifts, an aging population, and hereditary influences. Additionally, awareness programs and educational efforts have greatly enhanced public understanding of diabetes care. As a result, both patients and healthcare professionals are increasingly recognizing the advantages of modern insulin delivery systems, which provide more accurate dosing, greater ease of use, and better blood sugar management than conventional approaches.

Get a sneak peek at the Insulin Delivery Devices market dynamics @ https://www.delveinsight.com/report-store/insulin-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Coverage: Global
Study Period: 2022 to 2032
Key Insulin Delivery Devices Companies: Becton, Dickinson and Company, Medtronic, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo, CeQur, EOFLOW CO., LTD, European Pharma Group BV , Roche, Sanofi, Hindustan Syringes & Medical Devices Ltd , Ocean (Hangzhou) Medical Technology Co Ltd, Owen Mumford, SOOIL Developments Co., Ltd, SUNGSHIM MEDICAL CO., LTD., and others.

Which MedTech key players in the Insulin Delivery Devices market are set to emerge as the trendsetter, explore @ Insulin Delivery Devices Companies https://www.delveinsight.com/report-store/insulin-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Table of Contents
1. Insulin Delivery Devices Market Report Introduction
2. Insulin Delivery Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Insulin Delivery Devices Market Key Factors Analysis
6. Insulin Delivery Devices Market Porter's Five Forces Analysis
7. Insulin Delivery Devices Market Layout
8. Insulin Delivery Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Info:
Kritika Rehani
Assistant Manager, Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.